Crossmark

Cancer/testis antigen CAGE mediates osimertinib resistance in non-small cell lung cancer cells and predicts poor prognosis in patients with pulmonary adenocarcinoma

Crossref DOI link: https://doi.org/10.1038/s41598-023-43124-8

Published Online: 2023-09-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yeon, Minjeong

Lee, Hankyu

Yeo, Jeongseon

Jeong, Myeong Seon

Jung, Hyun Suk

Lee, Hyerim

Shim, Kyeonghee

Jo, Hyein

Jeon, Doyong

Koh, Jaemoon

Jeoung, Dooil
Funding

Funding for this research was provided by:

National Research Foundation of Korea (2020R1A2C1006996)
License Information

Text and Data Mining valid from 2023-09-21

Version of Record valid from 2023-09-21
More Information

Article History

Received: 22 July 2022

Accepted: 20 September 2023

First Online: 21 September 2023

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below